Log in

NYMXF Nymox Pharmaceutical Corp. OTC · Bahamas

Nymox Pharmaceutical (NYMXF) news

Latest Nymox Pharmaceutical news

We have not published a story on Nymox Pharmaceutical yet. When there is news, it will appear here.

Questions about Nymox Pharmaceutical

What is the ticker symbol of Nymox Pharmaceutical?

Nymox Pharmaceutical Corp. trades under the ticker NYMXF on OTC.

Where is Nymox Pharmaceutical listed?

Nymox Pharmaceutical Corp. is listed on OTC.

What is the SEC CIK of Nymox Pharmaceutical?

The SEC Central Index Key (CIK) for Nymox Pharmaceutical Corp. is 1018735. Its filings are on SEC EDGAR.

How many shares does Nymox Pharmaceutical have outstanding?

94,540,140 shares as of 2024-12-31, per the cover page of its 20-F filed 2025-06-03.

Which country or territory is Nymox Pharmaceutical listed under?

Our directory records Nymox Pharmaceutical Corp. under Bahamas.

What does Nymox Pharmaceutical do?

Our directory classifies Nymox Pharmaceutical Corp. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Nymox Pharmaceutical?

The ISIN recorded for Nymox Pharmaceutical Corp. is BSP733981026.

Does aibio.space cover Nymox Pharmaceutical?

aibio.space lists Nymox Pharmaceutical Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

What is the latest Nymox Pharmaceutical (NYMXF) stock news?

Our latest story on Nymox Pharmaceutical, dated May 1, 2025: "Nymox says 20-F is late, citing unfinished work and slow vendor replies to auditors". The company says it is still compiling required information for its annual report for the year ended December 31, 2024. Source.

Is Nymox Pharmaceutical in financial distress?

Our latest distress story, dated May 1, 2025: "Nymox says 20-F is late, citing unfinished work and slow vendor replies to auditors". The company says it is still compiling required information for its annual report for the year ended December 31, 2024. Source.

Is Nymox Pharmaceutical a smaller reporting company?

SEC records list Nymox Pharmaceutical Corp.'s filer category as: Accelerated filer.

Where is Nymox Pharmaceutical headquartered?

SEC records list its business address as 9900 CAVENDISH BLVD., SUITE 306, QUEBEC CANADA, Quebec, Canada, H4M 2V2.

When does Nymox Pharmaceutical's fiscal year end?

Nymox Pharmaceutical Corp.'s fiscal year ends on December 31, per SEC records.

What did Nymox Pharmaceutical last file with the SEC?

Its most recent filing in our record is a 20-F filed 2026-09-14. All of its filings are on SEC EDGAR. Source.

What industry is Nymox Pharmaceutical in?

Its SEC industry code (SIC 2835) is In Vitro & In Vivo Diagnostic Substances.

Investor discussion: Nymox Pharmaceutical

Members talk about Nymox Pharmaceutical (NYMXF). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Nymox Pharmaceutical, newest first. Each line links the filing it comes from.

  1. Distress

    Told the SEC a periodic report would be filed late. SEC Form NT 20-F. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:NYMXF on TradingView.

SEC filings and registration

SEC name
Nymox Pharmaceutical Corp
CIK
1018735
Industry (SIC)
In Vitro & In Vivo Diagnostic Substances (2835)
US tickers
NYMXF (OTC)
Fiscal year ends
December 31
Filer category
Accelerated filer
Business address
9900 CAVENDISH BLVD., SUITE 306, QUEBEC CANADA, Quebec, Canada, H4M 2V2
Phone
1-800-936-9669
Shares outstanding
94,540,140 as of 2024-12-31 (20-F filed 2025-06-03)

Recent filings (8-K and 6-K are the company's own announcements)

  • 20-F filed 2026-09-14
  • 6-K filed 2026-08-31
  • 6-K filed 2026-08-07
  • 6-K filed 2026-06-03
  • 6-K filed 2026-03-27
  • 6-K filed 2025-11-07
  • 6-K filed 2025-10-22
  • 6-K filed 2025-10-22

Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

Listing details

Nymox Pharmaceutical Corp. is a public biotech or pharmaceutical company listed on OTC under the ticker NYMXF, recorded under Bahamas. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Nymox Pharmaceutical Corp.
Ticker
NYMXF
Listing
OTC
Country or territory
Bahamas
Business scope
Pharmaceuticals: Major
ISIN
BSP733981026
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.